392 material Form 8-K filings that 341 companies we cover made with the SEC in July 2024, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Cabot Corporation appointed Thierry Vanlancker as a non-employee director and member of the Audit Committee, both effective July 12, 2024. He previously served as Chief Executive Officer and a Director of AkzoNobel NV from 2017 to 2022, and his term runs to the 2025 Annual Meeting of Stockholders.
Vanlancker elected to the Board effective July 12, 2024, and appointed to the Audit Committee on the same date.
Received Cabot common stock valued at about $77,500, a prorated share of the $155,000 annual non-employee director stock grant.
Previously CEO and a Director of AkzoNobel NV from 2017 to 2022; Chairman of the Board of SIKA AG since March 2024.
Ameris Bancorp notified Nasdaq on July 12, 2024 that it will voluntarily withdraw its common stock listing and transfer it to the New York Stock Exchange. The stock will keep the ABCB ticker and is expected to stop trading on Nasdaq at market close on July 22, 2024, and begin trading on the NYSE at market open on July 23, 2024. The filing does not report financial results, and the move does not change the company's share count or ticker.
Nasdaq listing expected to end at market close on July 22, 2024
NYSE listing expected to begin at market open on July 23, 2024
Common stock keeps the ticker ABCB; executives and board will ring the NYSE Opening Bell on July 23, 2024
Ameris manages $25.7 billion in assets as of March 31, 2024
BNY reported second-quarter 2024 results on July 12, 2024, with diluted earnings per share of $1.52, up 16% from a year earlier, and total revenue of $4.6 billion, up 2%. Excluding notable items, EPS was $1.51, up 9%. The company also raised its common dividend by 12% after the Federal Reserve's 2024 stress test, and returned $923 million to common shareholders in the quarter.
Diluted EPS of $1.52, up 16% year over year; $1.51 excluding notable items, up 9%
Total revenue of $4.6 billion, up 2%; noninterest expense of $3.1 billion, down 1%
Returned $923 million to common shareholders: $322 million in dividends and $601 million in share repurchases
Common dividend increased 12% starting in the second quarter; CET1 ratio of 11.4% versus 10.8% at March 31, 2024
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.